| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Aug―26 |
Metabolism configures immune response across multi-systems: Lessons from COVID-19 |
Tinku Gupta, Dhanya Rajendran, Akash Gujaral, Ashok Jangra |
| 2 |
[GO] |
2023―May―23 |
Circulating ACE2 level and zinc/albumin ratio as potential biomarkers for a precision medicine approach to COVID-19 |
Serena Benedetti, Davide Sisti, Daniela Vandini, Simone Barocci, Maurizio Sudano, Eugenio Carlotti, Jade Lee Lee Teng, Loris Zamai |
| 3 |
[GO] |
2022―Oct―17 |
Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes |
Jay Bhattacharya, Phillip Magness, Martin Kulldorff |
| 4 |
[GO] |
2022―Oct―08 |
COVID-19 models and expectations - Learning from the pandemic |
John P.A. Ioannidis, Stephen H. Powis |
| 5 |
[GO] |
2022―Oct―01 |
A consensus of evidence: The role of SPI-M-O in the UK COVID-19 response |
Graham F. Medley |
| 6 |
[GO] |
2022―Sep―30 |
Virus spread on a scale-free network reproduces the Gompertz growth observed in isolated COVID-19 outbreaks |
Francesco Zonta, Michael Levitt |
| 7 |
[GO] |
2022―Sep―24 |
Why COVID-19 modelling of progression and prevention fails to translate to the real-world |
Carl J. Heneghan, Tom Jefferson |
| 8 |
[GO] |
2022―Jul―19 |
Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trial |
Leon Peto, Peter Horby, Martin Landray |
| 9 |
[GO] |
2021―Aug―16 |
COVID-19 from a pharmacological perspective |
Giuseppe Remuzzi |
| 10 |
[GO] |
2021―Aug―12 |
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19? |
Mariele Montanari, Barbara Canonico, Evelyn Nordi, Daniela Vandini, Simone Barocci, Serena Benedetti, Eugenio Carlotti, Loris Zamai |
| 11 |
[GO] |
2021―Jul―23 |
Thromboprophylaxis in COVID-19 - Rationale and considerations |
Sotirios Bristogiannis, Dawn Swan, Jecko Thachil |
| 12 |
[GO] |
2021―Jul―15 |
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19 |
Emanuela Ricciotti, Krzysztof Laudanski, Garret A. FitzGerald |
| 13 |
[GO] |
2020―Jul―21 |
Where are we with understanding of COVID-19? |
Shaw M. Akula, James A. McCubrey |
| 14 |
[GO] |
2020―Jul―16 |
The clinical impact of COVID-19 epidemic in the hematologic setting |
Carlo Finelli, Sarah Parisi |
| 15 |
[GO] |
2020―Jul―09 |
Foreword for the special issue advances in COVID-19: Biology and clinic |
James A. McCubrey, Shaw M. Akula, Bernard Payrastre |
| 16 |
[GO] |
2020―Jul―04 |
Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression |
Günther Schönrich, Martin J. Raftery, Yvonne Samstag |
| 17 |
[GO] |
2020―Jun―26 |
Cancer therapy and treatments during COVID-19 era |
Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Saverio Candido, Massimo Libra, Kvin Lerpiriyapong, Lucio Cocco, Giulia Ramazzotti, Stefano Ratti, Matilde Y. Follo, Alberto M. Martelli, William L. Blalock, Manuela Piazzi, Giuseppe Montalto, Melchiorre Cervello, Monica Notarbartolo, Jorg Basecke, James A. McCubrey |
| 18 |
[GO] |
2020―Jun―20 |
Where are we with understanding of COVID-19? |
Shaw M. Akula, James A. McCubrey |
| 19 |
[GO] |
2020―Jun―17 |
Thromboembolic events and Covid-19 |
Agnès Ribes, Fanny Vardon-Bounes, Vincent Mémier, Michael Poette, Jonathan Au-Duong, Cédric Garcia, Vincent Minville, Pierre Sié, Alessandra Bura-Rivière, Sophie Voisin, Bernard Payrastre |
| 20 |
[GO] |
2020―Jun―17 |
SARS-CoV-2 pandemic: An overview |
Cecilia Acuti Martellucci, Maria Elena Flacco, Rosaria Cappadona, Francesca Bravi, Lorenzo Mantovani, Lamberto Manzoli |
| 21 |
[GO] |
2020―Jun―13 |
NK cells: A double edge sword against SARS-CoV-2 |
Elena Masselli, Mauro Vaccarezza, Cecilia Carubbi, Giulia Pozzi, Valentina Presta, Prisco Mirandola, Marco Vitale |
